170
Try Apretude, the first injectable HIV PrEP. Say goodbye to daily pills. Act fast, effective for men and women—quick, easy, and discreet.
Contact us at info.bkk@pulse-clinic.com or chat on your preferred platform:
+66 65 237 1936
@PULSEClinic
PulseClinic
Pre-exposure prophylaxis (PrEP) has transformed the fight against HIV by providing a preventive measure for those at high risk of acquiring the virus. While oral PrEP has been a game-changer, injectable PrEP, like Apretude, offers an innovative alternative, addressing adherence challenges and enhancing efficacy. Apretude (cabotegravir) is the first long-acting injectable PrEP approved for HIV prevention, providing consistent protection and convenience for users. In Bangkok, access to Apretude represents a critical step in reducing new HIV infections and improving public health.
The active ingredient in Apretude is cabotegravir, an integrase inhibitor that prevents the replication of HIV within the body. Unlike daily oral PrEP options (such as tenofovir disoproxil fumarate/emtricitabine), cabotegravir is administered via an intramuscular injection every two months, offering reliable protection for people at risk of HIV.
Recent guidelines by the World Health Organisation (WHO) and other health authorities recommend injectable PrEP as a viable alternative for individuals who face adherence challenges with daily pills. Key recommendations include:
These updated protocols emphasise the importance of comprehensive medical supervision to ensure safety and efficacy.
Apretude is administered via intramuscular injection in a healthcare setting. The standard protocol involves:
Healthcare providers in our Bangkok HIV Clinic will assess individual health status, perform regular HIV tests, and provide counselling on safe sex practices alongside PrEP use.
While generally well-tolerated, Apretude may cause side effects, including:
In rare cases, allergic reactions or liver function changes may occur. It's essential to let your healthcare provider know of any unusual symptoms as soon as possible.
Apretude is contraindicated for individuals:
Pregnant or breastfeeding individuals should consult their healthcare provider to evaluate risks and benefits.
Add us on Line and stay in touch.
Yes, Apretude is available in Bangkok. Please consult your healthcare provider or specialised clinics for more information on accessing it.
Clinical trials demonstrate Apretude's effectiveness in reducing HIV risk, surpassing oral PrEP in certain populations. A clinical trial found that people on Apretude injectable PrEP get 3 times less HIV compared to people using truvada.
Yes, transitioning from oral PrEP to Apretude is possible. Your healthcare provider will guide you through the switch to ensure seamless protection.
Apretude is an injectable PrEP that starts working as soon as you get the injection, unlike PrEP pills, which may be absorbed less by your body. A study found that Apretude provides maximum protection within 7 days for most people, and gives full protection in just 1 day for 50% of the people using injectable PrEP.
While injectable PrEP is an excellent option for many, it’s not suitable for individuals with certain health conditions or those who cannot commit to regular clinic visits.
The cost varies depending on the provider. Contact local clinics or organisations specialising in HIV prevention for pricing details.
Injectable PrEP, such as Apretude, marks a significant advancement in HIV prevention. Its superior adherence, convenience, and efficacy can potentially transform HIV prevention efforts in Bangkok. If you’re considering Apretude, consult your healthcare provider to determine if it’s the right choice.
For more information on Apretude (PrEP Injection) in Bangkok, contact our healthcare providers or HIV prevention organisations.
Add us on Line and stay in touch.